Phase 1 Dose Escalation and Drug Distribution Study of Oral Terameprocol in Patients with Recurrent High Grade Glioma

Grant

Date/time Interval

  • September 17, 2018 - April 30, 2021

    • Awarded By

    Total Award Amount

  • 26310.00

    • Direct Costs

  • 14866.00

    • Sponsor Award Id

  • ABTC 1401

    • Contributor

  • Hassan Fathallah-Shaykh M.D., Ph.D.   Investigator  
  • Louis Nabors M.D.   Principal Investigator  
  • Xiaosi Han   Investigator